CEBPB and C19MC mark TNBCs and potentially drive TNBCs from other molecular sub-types of breast cancer.

A, Schematic showing how CEBPB and REST play antagonistic roles in C19MC transcription to further regulate TNBC markers and REST mRNA to promote the triple negative status. B, Schematic showing how CEBPB and C19MC miRNAs act in concert to potentially drive TNBCs from other molecular sub-types of breast cancer.